Literature DB >> 2094581

Localization of CS and non-CS antigens in the sporogonic stages of Plasmodium yoelii.

M Aikawa1, C T Atkinson, L M Beaudoin, M Sedegah, Y Charoenvit, R Beaudoin.   

Abstract

Monoclonal antibodies (MAbs) and colloidal gold probes were used to localize circumsporozoite (CS) protein and two unrelated polypeptides in developing oocysts and salivary gland sporozoites of the 17X (NL) strain of Plasmodium yoelii. MAbs NYS1, NYS2, and NYS3 recognized different epitopes of the P. yoelii CS protein and produced similar patterns of immunolabelling on developing oocysts and sporozoites. A small percentage of oocysts contained developing sporoblasts and sporozoites that did not exhibit surface reactivity to MAbs NYS1, NYS2 or NYS3, although internal labelling was associated with endoplasmic reticulum (ER). These sporozoites were still capable of completing development and invading salivary glands where they could be found adjacent to sporozoites with densely labelled surface coats. If these sporozoites are infective, their presence may explain in part the failure of CS vaccines to completely protect immunized animals against challenge. The non-CS antigen recognized by MAbs NYS4 did not become abundant until late in sporogony. Some gold labelling was associated with the surface of budding and mature sporozoites, but the antigen was most abundant within the cytoplasm and micronemes. A second non-CS antigen identified by NYS5 first appeared in 7-day-old oocysts, although labelling was sparse. Small quantities of antigen appeared on the sporoblast membrane, cytoplasmic clefts and ER of oocysts and was associated with micronemes and the surface of budding and mature sporozoites. As the role played by non-CS antigens in the biology of the parasite is not yet known, further characterization of their function is needed before their potential as vaccine candidates can be determined.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2094581      PMCID: PMC2393049     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  9 in total

1.  Limited immunological recognition of critical malaria vaccine candidate antigens.

Authors:  M F Good; L H Miller; S Kumar; I A Quakyi; D Keister; J H Adams; B Moss; J A Berzofsky; R Carter
Journal:  Science       Date:  1988-10-28       Impact factor: 47.728

2.  Immunogold localization of circumsporozoite protein of the malaria parasite Plasmodium falciparum during sporogony in Anopheles stephensi midguts.

Authors:  G Posthuma; J F Meis; J P Verhave; M R Hollingdale; T Ponnudurai; J H Meuwissen; H J Geuze
Journal:  Eur J Cell Biol       Date:  1988-04       Impact factor: 4.492

3.  Expression of circumsporozoite proteins revealed in situ in the mosquito stages of Plasmodium berghei by the Lowicryl-immunogold technique.

Authors:  A J Hamilton; C S Davies; R E Sinden
Journal:  Parasitology       Date:  1988-04       Impact factor: 3.234

4.  Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax.

Authors:  R Rosenberg; R A Wirtz; D E Lanar; J Sattabongkot; T Hall; A P Waters; C Prasittisuk
Journal:  Science       Date:  1989-09-01       Impact factor: 47.728

5.  Immuno-electron microscopic observations on Plasmodium knowlesi sporozoites: localization of protective antigen and its precursors.

Authors:  E Fine; M Aikawa; A H Cochrane; R S Nussenzweig
Journal:  Am J Trop Med Hyg       Date:  1984-03       Impact factor: 2.345

6.  Localization of circumsporozoite protein of Plasmodium ovale in midgut oocysts.

Authors:  H Nagasawa; P M Procell; C T Atkinson; G H Campbell; W E Collins; M Aikawa
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

7.  Plasmodium malariae: distribution of circumsporozoite protein in midgut oocysts and salivary gland sporozoites.

Authors:  H Nagasawa; M Aikawa; P M Procell; G H Campbell; W E Collins; C C Campbell
Journal:  Exp Parasitol       Date:  1988-06       Impact factor: 2.011

8.  Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites.

Authors:  D A Herrington; D F Clyde; G Losonsky; M Cortesia; J R Murphy; J Davis; S Baqar; A M Felix; E P Heimer; D Gillessen
Journal:  Nature       Date:  1987 Jul 16-22       Impact factor: 49.962

9.  Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens.

Authors:  Y Charoenvit; M F Leef; L F Yuan; M Sedegah; R L Beaudoin
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

  9 in total
  11 in total

1.  Localization of circumsporozoite protein in the sporogonic stages of Plasmodium vivax.

Authors:  J F Meis; H Croes; B Mons; A van Belkum; T Ponnudurai
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

2.  A new antigen of Cryptosporidium parvum micronemes possessing epitopes cross-reactive with macrogamete granules.

Authors:  A Bonnin; J F Dubremetz; P Camerlynck
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

Review 3.  Cell invasion by the vertebrate stages of Plasmodium.

Authors:  P Sinnis; B K Sim
Journal:  Trends Microbiol       Date:  1997-02       Impact factor: 17.079

4.  Antibodies against thrombospondin-related anonymous protein do not inhibit Plasmodium sporozoite infectivity in vivo.

Authors:  S Gantt; C Persson; K Rose; A J Birkett; R Abagyan; V Nussenzweig
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

5.  Levels of circumsporozoite protein in the Plasmodium oocyst determine sporozoite morphology.

Authors:  Vandana Thathy; Hisashi Fujioka; Soren Gantt; Ruth Nussenzweig; Victor Nussenzweig; Robert Ménard
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

6.  Characterization of Plasmodium falciparum sporozoite surface protein 2.

Authors:  W O Rogers; A Malik; S Mellouk; K Nakamura; M D Rogers; A Szarfman; D M Gordon; A K Nussler; M Aikawa; S L Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

7.  Localisation of laminin within Plasmodium berghei oocysts and the midgut epithelial cells of Anopheles stephensi.

Authors:  Adéla Nacer; Karen Walker; Hilary Hurd
Journal:  Parasit Vectors       Date:  2008-09-22       Impact factor: 3.876

8.  Exit of Plasmodium sporozoites from oocysts is an active process that involves the circumsporozoite protein.

Authors:  Qian Wang; Hisashi Fujioka; Victor Nussenzweig
Journal:  PLoS Pathog       Date:  2005-09-30       Impact factor: 6.823

9.  Effect of chloroquine on gene expression of Plasmodium yoelii nigeriensis during its sporogonic development in the mosquito vector.

Authors:  Henrique Silveira; Susana Ramos; Patrícia Abrantes; Luís Filipe Lopes; Virgílio E do Rosario; Mitchell S Abrahamsen
Journal:  Malar J       Date:  2007-07-02       Impact factor: 2.979

10.  Effect of ingested human antibodies induced by RTS, S/AS01 malaria vaccination in children on Plasmodium falciparum oocyst formation and sporogony in mosquitoes.

Authors:  Kazutoyo Miura; Erik Jongert; Bingbing Deng; Luwen Zhou; John P Lusingu; Chris J Drakeley; Michael P Fay; Carole A Long; Johan Vekemans
Journal:  Malar J       Date:  2014-07-09       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.